UK-based robotics company CMR Surgical this morning announced a $600 million Series D.This latest round, led by SoftBank’s Vision Fund 2 and co-led by Ally Bridge Group, joins an existing $384.8 ...

CMR Surgical announces more than 100 Versius systems installed globally CMR is delivering on its commercial strategy of rapid global expansion with systems installed across the world and more than ...

CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity CapitalThe latest funding will fuel the global commercialisation of its ...

CMR Surgical is aiming to keep up the momentum as its minimally invasive robotic system continues to roll out around the globe, and the U.K. company has now raised 133 million pounds sterling ...

UK-based medical device company CMR Surgical has put itself up for sale at a valuation of up to $4 billion, the Financial Times reported on Tuesday, citing sources familiar with the matter.

T2-weighted cardiovascular magnetic resonance imaging (T2W-CMR) has been championed as the best noninvasive method to determine the myocardial area at risk and to quantify myocardial salvage in ...

UK medical robotics group CMR Surgical has put itself up for sale, seeking a valuation of as much as $4bn as the company plots its launch in the US, the biggest surgery market globally.